文献速递临床试验与 GCP

射血分数保留的心力衰竭患者联合耐力与抗阻运动训练:一项随机对照试验

Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial.
PubMed 文献 · Nat Med · 2025-01-02

这项多中心随机试验在322例射血分数保留的心力衰竭患者中评估12个月联合耐力与抗阻训练对比常规治疗的效果。主要终点改良Packer评分未达显著差异(Kendall's tau-b=-0.073,P=0.17),但运动组峰值摄氧量(均差1.3 ml kg-1 min-1,95%CI 0.4-2.1)和NYHA分级(OR=7.77,95%CI 3.73-16.21)改善优于常规治疗组。

要点

  • 12个月联合耐力与抗阻训练未显著改善改良Packer评分(P=0.17)。
  • 运动组峰值摄氧量较常规治疗组平均提高1.3 ml kg-1 min-1(95%CI 0.4-2.1)。
  • 运动组NYHA分级改善的OR为7.77(95%CI 3.73-16.21)。

核心结论

  • 1年联合耐力与抗阻运动训练未使改良Packer评分显著优于常规治疗,但峰值摄氧量和NYHA分级等重要临床参数较常规治疗改善。

研究设计与样本

  • 多中心随机对照试验,322例射血分数保留的心力衰竭患者按1:1随机分入运动训练组或常规治疗组,干预期12个月。
  • 患者平均年龄70岁,女性192例(59.6%),男性130例(40.4%)。

主要发现

  • 12个月时改良Packer评分改善者运动训练组33例(20.5%)vs 常规治疗组13例(8.1%),恶化者运动训练组69例(42.9%)vs 常规治疗组71例(44.1%)(Kendall's tau-b=-0.073,P=0.17)。
  • 峰值摄氧量变化的均差为1.3 ml kg-1 min-1(95%CI 0.4-2.1),利于运动训练组。
  • NYHA分级变化的OR=7.77(95%CI 3.73-16.21),利于运动训练组。
  • E/e'变化、GSA变化、心血管住院时间及全因死亡率等其他次要终点组间无显著差异。

关键数值与推荐

  • 主要终点为改良Packer评分,包含全因死亡、归类为可能与心力衰竭或运动相关的住院、峰值摄氧量变化、舒张功能(E/e')、NYHA分级和整体自评(GSA)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Endurance exercise training (ET) is an effective treatment in heart failure with preserved ejection fraction (HFpEF), but the efficacy of resistance training in this patient population has been only scarcely evaluated. In this multicenter, randomized trial, we evaluated the effects of combined endurance and resistance training over 12 months in patients with HFpEF. The primary endpoint was a modified Packer score, including all-cause mortality, hospitalizations classified as potentially related to heart failure or exercise and changes in peak oxygen consumption ( V ̇ O 2 ), diastolic function (E/e'), New York Heart Association (NYHA) class and global self-assessment (GSA). In total, 322 patients (mean age, 70 years; 192 females (59.6%) and 130 males (40.4%)) were randomized (1:1) to ET or usual care (UC). At 12 months, the modified Packer score showed an improvement in 33 ET patients (20.5%) and in 13 UC patients (8.1%) and showed a worsening in 69 ET patients (42.9%) and in 71 UC patients (44.1%) (Kendall's tau-b = -0.073, P = 0.17). Although the primary endpoint was not met, clinically relevant differences favoring the ET group as compared to the UC group were observed for the following secondary endpoints: changes in peak V ̇ O 2 (mean difference, 1.3 ml kg-1 min-1 (95% confidence interval (CI): 0.4-2.1)) and NYHA class (odds ratio = 7.77 (95% CI: 3.73-16.21)). No significant between-group differences were observed for other secondary endpoints, including change in E/e', change in GSA, time to cardiovascular hospitalization or all-cause mortality. In conclusion, 1 year of combined endurance and resistance ET did not result in a significantly better modified Packer score, but it did result in improvements in important clinical parameters, such as peak V ̇ O 2 and NYHA class, as compared to UC. ISRCTN registration: ISRCTN86879094 .

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Edelmann F, Wachter R, Duvinage A, et al. Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial. Nat Med. 2025. PMID: 39747684. doi:10.1038/s41591-024-03342-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。